Navigation Links
Testing genes for disease does not cause harm to children of people with Alzheimers

Testing for risk of Alzheimers disease in children of patients with Alzheimers// was thought to be harmful to them. It was suggested that such genetic testing might increase the anxiety or depression in children of the parents with Alzheimers. A new study points out that this may not be true. Genetical testing has no effect on the mental health of offsprings of patients with Alzheimers. Often the participants of the study felt empowered from knowing the test results.

Researchers from Boston University School of Medicine had conducted the study that had focused on the genetical testing for the biomarker ApoE4, which is the part of the apolipoprotein E (APOE) gene of adult children of patients with Alzheimers. ApoE4 is linked with incidence of Alzheimer's disease. The data was a comparison between two sets of participants, one who were told that they are either positive or negative in the test, and the other group, where the participants did not know of their gene test status.

The results showed no significant difference in their test results taken for depression and anxiety between the two groups. More than 90% of the total participants for the study said that they would choose the test for assessing their risk to the disease again and 82% said that they would refer their other family members and friends also to go for it.

Reference: Boston University School of Medicine, news release, June 2005
'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. Testing for blood sugar levels made easier
4. DNA Testing For More Accurate Results
5. SARS vaccine shows promise in Animal Testing
6. Testing Of Saliva May Predict Dental Caries
7. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
8. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
9. Testing For HIV/AIDS Compulsory For New Military Recruits
10. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
11. Eye Diseases Diagnosed Through Genetical Testing

Post Your Comments:
(Date:11/25/2009)...s,andPressJoinEfforttoEducate ,, MEMPHIS,Tenn....nalBipolarFoundationandtheMedicAlertFoundationrece...ram,whichisnowbeingwidelyacceptedasapreventiveheal...ipolarFoundationreceivedaproclamationofendorsement...ouisianaMitchLandrieu.TheNationalBipolarFoundation...
(Date:11/25/2009)...istically significant survival benefit from adjuva...r (ER)-positive tumors had high levels of phosphor...P), according to a brief communication published o...Cancer Institute . , Approximately 50% of breast...l studies have shown that ER-alpha S118-P is requi...
(Date:11/25/2009)...s simple question has been the focus of intense re...dulates High Blood Pressure in Mice & Men, Does s...on has been the focus of intense research for many...stablished a link between a novel gene, phosducin,... as well as humans. The studies were directed by s...
(Date:11/25/2009)... arthritis, could help newly diagnosed diabetics, ...thDay News) -- A drug commonly used to treat non-H...o shows some promise in helping patients newly dia...mab (Rituxan), helped patients keep producing some... destroyed some of their pancreatic beta cells, wh...
(Date:11/25/2009)...o overlook needed care, study finds , , ...depression can worsen her child,s asthma, U.S. res... 262 black mothers and their children found that c... had more frequent asthma symptoms, while children...s frequent asthma symptoms. , The Johns Hopkins...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
...ers' access to a high-profile detainee at Guantana...gation //techniques "national security secrets" wh...", the Washington Post reported Saturday. The U..., the Post reported. A lawyer at a firm that re...
...nosed on November 3, 1906. One hundred years after...ng on neuroscience, immunology and vaccine researc...D develops and progresses. Researchers at the Yerk...in disorder. About 20 million Americans are curren...
...mune system to control HIV infection appears to de...ystem molecules// called HLA Class I that have bee...protein those molecules display to the T lymphocyt...achusetts General Hospital (PARC/MGH) report that ...
...een simmering in the trans-fat controversy for qui...r sticky ally- the hydrogenated// vegetable oils! ... KFC, Marks & Spencer, Asda, Sainsbury’s and Tesco... to bring in a law that would entail manufacturers...
...patients who behave in an unbecoming manner, and w...e by an NHS hospital to punish patients// that dis...avior. The Royal Bolton hospital in Greater...ts of violence in hospitals where security staff h...
...agazine for men with a tall worldwide readership o... survey that queried almost 40,000 men// from 43 c... habits. An exclusive feature titled "World's Best...indulged in one night escapades. All the same, Ind...
Other Medicine News:Health News:Genes determine the capacity to fight HIV in early stages 2Health News:Genes determine the capacity to fight HIV in early stages 3
(Date:11/25/2009)...swire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),a...vering,developingandcommercializingnoveldrugstotre...scalyearendedSeptember30,2009.AtSeptember30,2009Ph...hortterminvestments. ,, PipelineUpdateand2009H..., InlateNovember2009,anindependentDataMonitorin...
(Date:11/25/2009)...,Nov.25/PRNewswire/-- FromNovember16-18,Phonak,the...esentedthesecondeditionoftheHearingCareforAdultsCo...tion.Theconferencebroughttogetherleadingexpertsina...inicianswhoworkeverydaywitholderpeoplewithhearingl...latestresearchandtrendsinhearingcareforolderpeople...
(Date:11/25/2009)...ewswire/--TheFDAgrantedtraditionalapprovalforINTEL...setranscriptaseinhibitor(NNRTI).INTELENCEistheonly...encedadultswhoareexperiencingvirologicfailurewithH...l(ARV)agents.Thetraditionalapprovalisbasedon48-wee...TELENCEiscurrentlymarketedintheU.S.byTibotecTherap...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 1Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3
...one Systems Incorporated,(Nasdaq: IMCL ) and Bris...nced,that the U.S. Food and Drug Administration (F...ximab) product labeling to include overall surviva...r inhibitor,(EGFR)-expressing metastatic colorecta...notecan- and oxaliplatin-based regimens. The appr...
...cond Cerimon Product Candidate to Enter Clinical ...SAN FRANCISCO, Oct. 2 Cerimon Pharmaceuticals,Inc...ical study of a novel,diclofenac sodium patch, the...e safety, tolerability, and systemic pharmacokinet...odium, a non-steroidal anti-inflammatory,drug (NSA...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3
Liquichek D-dimer Control
... use in assessing compliance with specimen handlin...f custody, for Federal Workplace Drug Testing Prog...ealth Services Administration (SAMHSA), Health and... agencies. These samples are confirmed negative fo...
Liquichek Reticulocyte Stain
Seroconversion and Antigen Panel Chart
Medicine Products: